THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA

THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA

abstract Background: Beta thalassemia is an inherited hemoglobin disorder resulting in chronic hemolytic anemia requiring life-long blood transfusion that cause iron overload. Silymarin plays a role as oral iron chelator and hepatoprotective agents in thalassemic patients.The aim of this work was to...

Full description

Bibliographic Details
Main Author:	adel abd elhaleim hagag
Format:	Article
Language:	English
Published:	Mattioli1885 2013-11-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	thalassemia
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/458

Similar Items

Combination iron chelation therapy with deferiprone and deferasirox in iron-overloaded patients with transfusiondependent β-thalassemia major
by: Hossein Karami, et al.
Published: (2017-01-01)

Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia
by: Murtadha Al-Khabori, et al.
Published: (2013-03-01)

A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan
by: Wan-Ling Ho, et al.
Published: (2013-04-01)

Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine
by: Mohamed Abdel Malik Hassan, et al.
Published: (2016-05-01)

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia
by: Pennell, D.J., et al.
Published: (2010)

Iron overload in non-transfusion-dependent thalassemia
by: Khaled M. Musallam
Published: (2013-03-01)

THE ANTIOXIDANT EFFECTS OF CAPPARIS OVATA AND DEFERASIROX IN PATIENTS WITH THALASSEMIA MAJOR
by: Handan Duman, et al.
Published: (2014-08-01)

Comparison of deferasirox and deferoxamine effect on liver enzyme activities and ferritin level in patients with beta-thalassemia
by: Rasul Jameel Ali, et al.
Published: (2020-12-01)

Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series
by: Valeria Maria Pinto, et al.
Published: (2020-11-01)

Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes
by: Ricchi P, et al.
Published: (2015-12-01)

Iron deficiency anemia: an instrument in the propagation of beta thalassemia gene
by: Muhammad Usman
Published: (2014-08-01)

Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
by: Ghazaiean Mobin, et al.
Published: (2023-07-01)

Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review
by: Romadhon PZ, et al.
Published: (2022-11-01)

Glutathione S transferase polymorphisms influence on iron overload in β-thalassemia patients
by: Serena Sclafani, et al.
Published: (2013-11-01)

Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients
by: Abdulzahra Mohammed, et al.
Published: (2011-01-01)

Study of the effect of HFE gene mutations on iron overload in Egyptian thalassemia patients
by: Manal Michel Wilson, et al.
Published: (2015-04-01)

Iron overload and chelation therapy in hemoglobinopathies
by: Rayan Bou-Fakhredin, et al.
Published: (2018-04-01)

Cardiac Magnetic Resonance Strain in Beta Thalassemia Major Correlates with Cardiac Iron Overload
by: Deidra Ansah, et al.
Published: (2023-01-01)

Oxidative Stress (Malondialdehyde) in Adults Beta-Thalassemia Major and Intermedia: Comparison Between Before and After Blood Transfusion and Its Correlation with Iron Overload
by: Atmakusuma TD, et al.
Published: (2021-10-01)

Prevalence of Co-Inheritance of Alpha-Thalassemia with Beta-Thalassemia and Beta-Hemoglobinopathy in Ahvaz City
by: Najmaddin Saki, et al.
Published: (2013-09-01)

Frequency of hereditary hemochromatosis gene mutations and their effects on iron overload among beta thalassemia patients of Chennai residents
by: Bhuvana Selvaraj, et al.
Published: (2021-11-01)

Correlation between QRS Complex Changes and Cardiac Iron Overload in Beta Thalassemia Major Patients Using T2*MRI
by: Mohammad Amini, et al.
Published: (2021-04-01)

Pengaruh Deferasirox Terhadap Kadar T4 dan TSH Pada B-Thalassemia Mayor dengan Kadar Ferritin Tinggi
by: Dewi Ratih P, et al.
Published: (2016-11-01)

Comparative analysis of deferasirox and deferiprone iron chelator on the growth pattern of Bengali β-thalassemia major children of West Bengal, India
by: Isita Tripathy, et al.
Published: (2022-09-01)

Lens opacity as a serious side effect following chelation therapy in beta thalassemia: A comparison between deferoxamine and deferasirox; randomized double-blinded clinical trial
by: Mohammad Reza Golpayegani, et al.
Published: (2019-01-01)

Comparison of the Effects of Deferasirox (Nanojade®) and Deferoxamine (Desferal®) on Serum Ferritin Level Changes in Major Beta-Thalassemia Patients: A Randomized Clinical Trial
by: saeedeh Khorashadi Zadeh, et al.
Published: (2023-12-01)

Comparison of Deferiprone to Deferasirox and Deferoxamine to Cardiac and Hepatic T2* MRI in Thalassemia Patients: Evidence-based Case Report
by: Pustika Amalia Wahidiyat, et al.
Published: (2018-06-01)

Pathogen-Associated Molecules from Gut Translocation Enhance Severity of Cecal Ligation and Puncture Sepsis in Iron-Overload β-Thalassemia Mice
by: Sae-khow K, et al.
Published: (2020-10-01)

Role of Vitamin C Supplementation on Iron Overload and Oxidative Stress in Beta Thalassemia Major Patients in Maysan Province-Iraq
by: Jafar Hussien, et al.
Published: (2021-12-01)

Hypoparathyroidism in Adult Patients with Beta-Thalassemia Major
by: Gihan Ali A M Sleem, et al.
Published: (2007-12-01)

The Status of Iron Stores in the Women with Beta Thalassemia Minor
by: Tahsin KARAASLAN, et al.
Published: (2021-10-01)

Pulmonary dysfunction in children with beta thalassemia major in relation with iron overload - a cross sectional hospital based study
by: A Boddu
Published: (2015-04-01)

Diagnostic Value of T1 Mapping in Detecting Iron Overload in Indian Patients with Thalassemia Major: A Comparison with T2* Mapping
by: Surya Pratap Singh, et al.
Published: (2024-01-01)

Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review
by: Subhangi Basu, et al.
Published: (2023-07-01)

Left ventricular deformation mechanics over time in patients with thalassemia major with and without iron overload
by: Michael J. Bonios, et al.
Published: (2021-02-01)

Hepatitis C pada Thalassemia mayor: pengaruh Iron Overload pada perjalanan penyakit
by: Ferry Damardjati, et al.
Published: (2016-12-01)

Role of malonaldehyde as a surrogate biomarker for iron overload in the β-thalassemia patient: A systematic meta-analysis
by: Debleena Basu, et al.
Published: (2021-12-01)

Prevalence of iron deficiency anemia and beta thalassemia carriers among relatives of beta thalassemia patients in Nile Delta region, Egypt: a multicenter study
by: Mohamed R. El-Shanshory, et al.
Published: (2021-10-01)

Use of Deferasirox Film-Coated Tablets in Pediatric Patients with Transfusion Dependent Thalassemia: A Single Center Experience
by: Alkistis Adramerina, et al.
Published: (2022-02-01)

The Correlation Between Iron Overload and Endocrine Function in Adult Transfusion-Dependent Beta-Thalassemia Patients with Growth Retardation
by: Atmakusuma TD, et al.
Published: (2021-08-01)